US Stock MarketDetailed Quotes
GNLX Genelux
Watchlist
12.380
-0.460-3.58% Close 12/11 16:00 ET
12.3800.0000.00%
Post 16:01 ET
13.370High12.180Low87.97KVolume
12.810Open12.840Pre Close1.11MTurnover0.44%Turnover RatioLossP/E (TTM)330.76MMarket Cap40.98052wk HighLossP/E (Static)26.72MShares5.35052wk Low13.77P/B248.77MFloat Cap40.980Historical High--Dividend TTM20.09MShs Float5.350Historical Low--Div YieldTTM9.27%Amplitude12.633Avg Price1Lot Size
About Genelux Company
Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.
Company Profile
SymbolGNLX
Company NameGenelux
Listing Date01/26/2023
Issue Price6.00
Founded2001
CEOMr. Thomas Zindrick, J.D.
MarketNASDAQ
Employees15
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2625 Townsgate Road,Suite 230
CityWestlake Village
ProvinceCalifornia
CountryUnited States of America
Zip Code91361
Phone1-858-267-9889
Websitehttp://www.genelux.com
Company Executives
- Name
- Position
- Salary
- Thomas Zindrick, J.D.
- Chairman of the Board, President and Chief Executive Officer
- 500.00K
- Lourie S. Zak
- Chief Financial Officer and Principal Accounting Officer
- --
- John W. Smither
- Independent Director
- --